Indeed, CCN2 has been reported to promote tumorigenesis in many cancer types, including pancreatic cancer, prostate cancer, lung cancer, breast cancer [27–29] among others [30, 31]. This evidence concerns the gene CCN2 and familial pancreatic carcinoma.